MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells

Biochemical Journal

Volumn 444, Issue 1, 2012, Pages 105-114

  Ginnan, Roman ^a   Sun, Li Yan ^a   Schwarz, John J ^a   Singer, Harold A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Ca2+ calmodulin dependent protein kinase II (CaMKII); Gene transcription; Histone deacetylase (HDAC); Myocyte enhancer factor 2 (MEF2); Vascular smooth muscle cell (VSMC)

Indexed keywords

ANGIOTENSIN II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DNA; HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; IONOMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOCYTE ENHANCER FACTOR 2; NUCLEAR RECEPTOR NUR77; PLATELET DERIVED GROWTH FACTOR; POLYCLONAL ANTIBODY; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE TARGETING; GENETIC TRANSCRIPTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CHEMOKINE CCL2; HISTONE DEACETYLASES; ISOENZYMES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; MYOGENIC REGULATORY FACTORS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PLATELET-DERIVED GROWTH FACTOR; PROTEIN MULTIMERIZATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 84860797875     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120152     Document Type: Article

References (55)

1. Owens, G. K., Kumar, M. S. and Wamhoff, B. R. (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801 (Pubitemid 38823766)
2. Lindqvist, A., Nilsson, B. O., Ekblad, E. and Hellstrand, P. (2001) Platelet-derived growth factor receptors expressed in response to injury of differentiated vascular smooth muscle in vitro: effects on Ca2+ and growth signals. Acta Physiol. Scand. 173, 175-184 (Pubitemid 32989450)
3. Gollasch, M., Haase, H., Ried, C., Lindschau, C., Morano, I., Luft, F. C. and Haller, H. (1998) L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J. 12, 593-601 (Pubitemid 28183518)
4. 2+ handling in vascular smooth muscle cells is affected by proliferation. Arterioscler. Thromb. Vasc. Biol. 20, 1225-1235
5. CRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J. 23, 2425-2437
6. Inoue, R., Jensen, L. J., Shi, J., Morita, H., Nishida, M., Honda, A. and Ito, Y. (2006) Transient receptor potential channels in cardiovascular function and disease. Circ. Res. 99, 119-131 (Pubitemid 44297035)
7. Wamhoff, B. R., Bowles, D. K. and Owens, G. K. (2006) Excitation-transcription coupling in arterial smooth muscle. Circ. Res. 98, 868-878
8. Barlow, C. A., Rose, P., Pulver-Kaste, R. A. and Lounsbury, K. M. (2006) Excitation-transcription coupling in smooth muscle. J. Physiol. 570, 59-64
9. House, S. J. and Singer, H. A. (2008) CaMKII-δ isoform regulation of neointima formation after vascular injury. Arterioscler. Thromb. Vasc. Biol. 28, 441-447
10. Rokolya, A. and Singer, H. A. (2000) Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am. J. Physiol. Cell Physiol. 278, C537-C545 (Pubitemid 30154933)
11. 2+/calmodulin-dependent kinase IIδ(CaMKIIδ) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21. J. Biol. Chem. 286, 7990-7999
12. 2+/calmodulin-dependent protein kinase II-δ isoform regulation of vascular smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 292, C2276-C2287
13. 2-dependent regulation of vascular smooth muscle cell polarization and migration. Am. J. Physiol. Cell Physiol. 294, C1465-C1475
14. Vong, L., Bi, W., O'Connor-Halligan, K. E., Li, C., Cserjesi, P. and Schwarz, J. J. (2006) MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field. Dev. Dyn. 235, 1809-1821 (Pubitemid 43902340)
15. Naya, F. J., Black, B. L., Wu, H., Bassel-Duby, R., Richardson, J. A., Hill, J. A. and Olson, E. N. (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8, 1303-1309 (Pubitemid 35373564)
16. Li, H., Radford, J. C., Ragusa, M. J., Shea, K. L., McKercher, S. R., Zaremba, J. D., Soussou, W., Nie, Z., Kang, Y. J., Nakanishi, N. et al. (2008) Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc. Natl. Acad. Sci. U.S.A. 105, 9397-9402
17. De Val, S., Anderson, J. P., Heidt, A. B., Khiem, D., Xu, S. M. and Black, B. L. (2004) Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev. Biol. 275, 424-434 (Pubitemid 40288096)
18. Potthoff, M. J. and Olson, E. N. (2007) MEF2: a central regulator of diverse developmental programs. Development 134, 4131-4140
19. Anderson, J. P., Dodou, E., Heidt, A. B., De Val, S. J., Jaehnig, E. J., Greene, S. B., Olson, E. N. and Black, B. L. (2004) HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol. Cell. Biol. 24, 3757-3768 (Pubitemid 38496155)
20. Creemers, E. E., Sutherland, L. B., McAnally, J., Richardson, J. A. and Olson, E. N. (2006) Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133, 4245-4256 (Pubitemid 44830668)
21. Firulli, A. B., Miano, J. M., Bi, W., Johnson, A. D., Casscells, W., Olson, E. N. and Schwarz, J. J. (1996) Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells: association with the activated phenotype. Circ. Res. 78, 196-204 (Pubitemid 26042838)
22. Suzuki, E., Guo, K., Kolman, M., Yu, Y. T. and Walsh, K. (1995) Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol. Cell. Biol. 15, 3415-3423
23. Gordon, J. W., Pagiatakis, C., Salma, J., Du, M., Andreucci, J. J., Zhao, J., Hou, G., Perry, R. L., Dan, Q., Courtman, D. et al. (2009) Protein kinase A-regulated assembly of a MEF2·HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J. Biol. Chem. 284, 19027-19042
24. Miska, E. A., Karlsson, C., Langley, E., Nielsen, S. J., Pines, J. and Kouzarides, T. (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18, 5099-5107 (Pubitemid 29443811)
25. Zhang, T., Kohlhaas, M., Backs, J., Mishra, S., Phillips, W., Dybkova, N., Chang, S., Ling, H., Bers, D. M., Maier, L. S. et al. (2007) CaMKIIδ isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J. Biol. Chem. 282, 35078-35087 (Pubitemid 350232479)
26. Backs, J., Song, K., Bezprozvannaya, S., Chang, S. and Olson, E. N. (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864 (Pubitemid 44033310)
27. Backs, J., Backs, T., Bezprozvannaya, S., McKinsey, T. A. and Olson, E. N. (2008) Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol. Cell. Biol. 28, 3437-3445 (Pubitemid 351657105)
28. Ellis, J. J., Valencia, T. G., Zeng, H., Roberts, L. D., Deaton, R. A. and Grant, S. R. (2003) CaM kinase IIδC phosphorylation of 14-3-3β in vascular smooth muscle cells: activation of class II HDAC repression. Mol. Cell. Biochem. 242, 153-161 (Pubitemid 36240541)
29. Li, H., Li, W., Gupta, A. K., Mohler, P. J., Anderson, M. E. and Grumbach, I. M. (2010) Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 298, H688-H698
30. Pang, J., Yan, C., Natarajan, K., Cavet, M. E., Massett, M. P., Yin, G. and Berk, B. C. (2008) GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 28, 892-898 (Pubitemid 351544104)
31. Xu, X., Ha, C. H., Wong, C., Wang, W., Hausser, A., Pfizenmaier, K., Olson, E. N., McKinsey, T. A. and Jin, Z. G. (2007) Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27, 2355-2362 (Pubitemid 350203950)
32. 2+/calmodulin-dependent protein kinase II γ-subunit variants expressed in vascular smooth muscle, brain, and cardiomyocytes. J. Biol. Chem. 272, 9393-9400
33. 2+/calmodulin-dependent protein kinase II: differential expression in rat brain and aorta. J. Biol. Chem. 268, 14443-14449
34. 2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 286, C1281-C1289
35. Geisterfer, A. A., Peach, M. J. and Owens, G. K. (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62, 749-756
36. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ. Res. 81, 575-584
37. 2+/calmodulin- dependent protein kinase II in vascular smooth muscle cells. J. Biol. Chem. 271, 2506-2513
38. Pfleiderer, P. J., Lu, K. K., Crow, M. T., Keller, R. S. and Singer, H. A. (2004) Modulation of vascular smooth muscle cell migration by CaMKII. Am. J. Physiol. Cell Physiol. 286, C1238-C1245
39. Lu, K. K., Armstrong, S. E., Ginnan, R. and Singer, H. A. (2005) Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 289, C1343-C1350 (Pubitemid 41456851)
40. Dequiedt, F., Kasler, H., Fischle, W., Kiermer, V., Weinstein, M., Herndier, B. G. and Verdin, E. (2003) HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18, 687-698 (Pubitemid 36588585)
41. Lam, B. Y., Zhang, W., Ng, D. C., Maruthappu, M., Roderick, H. L. and Chawla, S. (2010) CREB-dependent Nur77 induction following depolarization in PC12 cells and neurons is modulated by MEF2 transcription factors. J. Neurochem. 112, 1065-1073
42. Suzuki, E., Satonaka, H., Nishimatsu, H., Oba, S., Takeda, R., Omata, M., Fujita, T., Nagai, R. and Hirata, Y. (2004) Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway. Circ. Res. 95, 42-49 (Pubitemid 38931834)
43. Parra, M. and Verdin, E. (2010) Regulatory signal transduction pathways for class IIa histone deacetylases. Curr. Opin. Pharmacol. 10, 454-460
44. Ha, C. H., Wang, W., Jhun, B. S., Wong, C., Hausser, A., Pfizenmaier, K., McKinsey, T. A., Olson, E. N. and Jin, Z. G. (2008) Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. J. Biol. Chem. 283, 14590-14599
45. Jones, R. J., Jourd'heuil, D., Salerno, J. C., Smith, S. M. and Singer, H. A. (2007) iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 292, H2634-H2642 (Pubitemid 47084512)
46. Paroni, G., Cernotta, N., Dello, R. C., Gallinari, P., Pallaoro, M., Foti, C., Talamo, F., Orsatti, L., Steinkuhler, C. and Brancolini, C. (2008) PP2A regulates HDAC4 nuclear import. Mol. Biol. Cell 19, 655-667 (Pubitemid 351272153)
47. Parra, M., Mahmoudi, T. and Verdin, E. (2007) Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes. Genes Dev. 21, 638-643 (Pubitemid 46440285)
48. 2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J. Neurochem. 68, 2119-2128
49. 2+/calmodulin-dependent protein kinase II associated with an endoplasmic reticulum stress response in vascular smooth muscle. Mol. Cell. Biochem. 213, 83-92
50. Chang, S., Young, B. D., Li, S., Qi, X., Richardson, J. A. and Olson, E. N. (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321-334 (Pubitemid 44092958)
51. Fritzer, A., Noiges, B., Schweiger, D., Rek, A., Kungl, A. J., von, G. A., Nagy, E. and Meinke, A. L. (2009) Chemokine degradation by the Group A streptococcal serine proteinase ScpC can be reconstituted in vitro and requires two separate domains. Biochem. J. 422, 533-542
52. Youn, H. D. and Liu, J. O. (2000) Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13, 85-94
53. Pires, N. M., Pols, T. W., de Vries, M. R., van Tiel, C. M., Bonta, P. I., Vos, M., Arkenbout, E. K., Pannekoek, H., Jukema, J. W., Quax, P. H. and de Vries, C. J. (2007) Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation 115, 493-500 (Pubitemid 46184201)
54. Arkenbout, E. K., de Waard, V., van Braqt, M., van Achterberg, T. A., Grimbergen, J. M., Pichon, B., Pannekoek, H. and de Vries, C. J. (2002) Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 106, 1530-1535
55. Davis, F. J., Gupta, M., Camoretti-Mercado, B., Schwartz, R. J. and Gupta, M. P. (2003) Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4: implications in cardiac muscle gene regulation during hypertrophy. J. Biol. Chem. 278, 20047-20058 (Pubitemid 36799198)